Evaluation of anti-nNav1.5 antibodies as potential therapeutic agent in suppressing breast cancer invasion and metastasis
Advanced-stage breast cancer has the poorest survival rates and contributes to 90% of cancer mortality, primarily due to limited molecular targets and treatment options. In this study, a novel target for metastatic breast cancer, a splice variant of Nav1.5 named ‘neonatal’ Nav1.5 (nNav1.5), a mem...
| المؤلف الرئيسي: | |
|---|---|
| التنسيق: | أطروحة |
| اللغة: | الإنجليزية |
| منشور في: |
2022
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | http://eprints.usm.my/57763/ |
| Abstract | Abstract here |